Evidence map›Paper›PMID 30084953›Full record

ArticleBrain : a journal of neurology2018

GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia.

Ilse Eidhof, Jonathan Baets, Erik-Jan Kamsteeg, Tine Deconinck, Lisa van Ninhuijs, Jean-Jacques Martin, Rebecca Schüle, Stephan Züchner, Peter De Jonghe, Annette Schenck and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ataxia-associated DNA repair genes protect theFrontiers in neural circuits · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Autosomal recessive adult onset ataxia.Journal of neurology · 2022
    Article
  14. The Journal of biological chemistry · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Ilse EidhofDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, GA Nijmegen, The Netherlands.
Jonathan BaetsNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
Erik-Jan KamsteegDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, GA Nijmegen, The Netherlands.
Tine DeconinckNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
Lisa van NinhuijsDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, GA Nijmegen, The Netherlands.
Jean-Jacques MartinInstitute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Rebecca SchüleDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
Stephan ZüchnerDr. John T. Macdonald Foundation, Department of Human Genetics, Miami, USA.
Peter De JongheNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
Annette SchenckDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, GA Nijmegen, The Netherlands.
Bart P van de WarrenburgDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, GC Nijmegen, The Netherlands.
Radboud University Nijmegen · NLUniversity of Antwerp · BEVIB-UAntwerp Center for Molecular Neurology · BEGerman Center for Neurodegenerative Diseases · DERadboud University Medical Center · NLUniversity of Miami · US

Funding

Uncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Michael Benatar · 2014 to 2026
$19.8M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
NINDS NIH HHS U54 NS092091
6 · The paper itself

Abstract

Autosomal recessive cerebellar ataxias are a group of rare disorders that share progressive degeneration of the cerebellum and associated tracts as the main hallmark. Here, we report two unrelated patients with a new subtype of autosomal recessive cerebellar ataxia caused by biallelic, gene-disruptive mutations in GDAP2, a gene previously not implicated in disease. Both patients had onset of ataxia in the fourth decade. Other features included progressive spasticity and dementia. Neuropathological examination showed degenerative changes in the cerebellum, olive inferior, thalamus, substantia nigra, and pyramidal tracts, as well as tau pathology in the hippocampus and amygdala. To provide further evidence for a causative role of GDAP2 mutations in autosomal recessive cerebellar ataxia pathophysiology, its orthologous gene was investigated in the fruit fly Drosophila melanogaster. Ubiquitous knockdown of Drosophila Gdap2 resulted in shortened lifespan and motor behaviour anomalies such as righting defects, reduced and uncoordinated walking behaviour, and compromised flight. Gdap2 expression levels responded to stress treatments in control flies, and Gdap2 knockdown flies showed increased sensitivity to deleterious effects of stressors such as reactive oxygen species and nutrient deprivation. Thus, Gdap2 knockdown in Drosophila and GDAP2 loss-of-function mutations in humans lead to locomotor phenotypes, which may be mediated by altered responses to cellular stress.

Indexed as

AdultAnimalsAtaxiaCerebellar AtaxiaCerebellumDrosophila melanogasterDrosophila ProteinsFemaleGene Knockdown TechniquesGenes, RecessiveGenetic Predisposition to DiseaseHumansMiddle AgedMutationNerve Tissue ProteinsPhenotypeDrosophila ProteinsGDAP proteinNerve Tissue Proteins

Identifiers

PMID30084953
PMCPMC7534050
OpenAlexW2885277872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.